Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| K08DA058057 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Drug Abuse (NIDA) | NIH |
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to develop a human laboratory model of resilience in people with opioid use disorder (OUD). The investigators aim to learn if objective tasks that measure cognitive, emotional, and control aspects of resilience match up with self-reported resilience during stress and non-stress situations.
This study is an outpatient, within-subject, randomized controlled trial designed to develop and validate a novel laboratory-based model for assessing resilience in individuals with opioid use disorder (OUD). The study employs a dual-condition design where participants complete two experimental sessions administered in a randomized order: one under a stress condition and one under a non-stress condition. In each session, participants will perform a series of standardized laboratory tasks aimed at evaluating cognitive, emotional, and control aspects of resilience. Objective measures (e.g., task performance data and physiological indices) and subjective ratings of stress reactivity will be collected to capture both behavioral and self-perceived responses.
Additionally, this study includes an administrative supplement focused on Natural Language Processing (NLP) phenotyping. A subset of participants who complete the primary human laboratory resilience assessments will participate in a semi-structured qualitative interview probing personal definitions and experiences of resilience and spirituality. The resulting narratives will be analyzed using AI and NLP methods to derive quantitative linguistic indices. These indices will be integrated with the parent study's behavioral and physiological data to determine if narrative markers of spirituality and resilience improve the prediction of stress-induced opioid demand and refine mechanistic models of OUD.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Stress-First Sequence | Experimental | Participants in this arm will first undergo the stress condition using the Maastricht Acute Stress Test (MAST) and then complete the non-stress condition (NST) in a subsequent session. |
|
| Non-Stress-First Sequence | Experimental | Participants in this arm will first complete the non-stress condition (NST) and then undergo the stress condition using the Maastricht Acute Stress Test (MAST) in a subsequent session. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Acute Stress Intervention (MAST-based) | Behavioral | This intervention uses the Maastricht Acute Stress Test (MAST) to induce an acute stress response. Participants are exposed to standardized stress tasks while performing laboratory-based assessments of cognitive, emotional, and control aspects of resilience. |
| Measure | Description | Time Frame |
|---|---|---|
| Self-Reported Trait Resilience as assessed by Connor-Davidson Resilience Scale 25 (CD-RISC-25) | Instrument: Connor-Davidson Resilience Scale 25 Score Range: 0-100 Interpretation: Higher scores indicate greater resilience. | Immediately after completing the task |
| Cognitive Flexibility: Stroop Color-Word Test reaction time | Instrument: Stroop Color-Word Test Unit: Milliseconds (ms) Interpretation: Higher values = slower performance (worse) | Immediately after completing the task |
| Emotional Flexibility: Emotional Stroop Task reaction time | Instrument: Emotional Stroop Task Unit: Milliseconds (ms) Interpretation: Higher values = slower performance (worse). | Immediately after completing the task |
| Perceived Controllability (Controllable) assessed by Social Controllability Task (SCT) | Instrument: Social Controllability Task Description: Participants ratings on a 0-100% sliding scale. Interpretation: Higher scores indicate greater perceived control. | Immediately after completing the task |
| Measure | Description | Time Frame |
|---|---|---|
| Subjective Effects of Stress as assessed by the Subjective Effects Visual Analog Scale (VAS) Battery | Instrument: Subjective Effects Visual Analog Scale (VAS) Battery Instrument: VAS (0-100 mm) Interpretation: Higher scores indicate greater intensity of each subjective state. | Immediately after completing the task |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Suky Martinez, PhD | Contact | 410-550-0007 | smart209@jh.edu |
| Name | Affiliation | Role |
|---|---|---|
| Suky Martinez, PhD | Johns Hopkins University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johns Hopkins University Bayview Medical Campus | Not yet recruiting | Baltimore | Maryland | 21224 | United States | |
Not provided
| ID | Term |
|---|---|
| D009293 | Opioid-Related Disorders |
| ID | Term |
|---|---|
| D000079524 | Narcotic-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Non-Stress Intervention (NST-based) | Behavioral | In this control intervention, participants complete the same battery of laboratory tasks without exposure to the acute stressor. |
|
| Heart Rate |
Unit: Beats per minute (bpm) Interpretation: Higher = increased arousal |
| Immediately after completing the task |
| Systolic Blood Pressure | Unit: mmHg Interpretation: Higher = greater pressure. | Immediately after completing the task |
| Diastolic Blood Pressure | Unit: mmHg Interpretation: Higher = greater pressure. | Immediately after completing the task |
| Opioid Demand Breakpoint as assessed by the Hypothetical Purchase Task | Instrument: Hypothetical Purchase Task Range: $0-$500 Interpretation: Higher = greater demand. | Immediately after completing the task |
| Percentage of Resilience-themed Interview Content | This outcome is defined as the average percentage of narrative content within semi-structured qualitative interviews classified as "resilience-themed" using Latent Dirichlet Allocation (LDA). This measure quantifies the relative focus a participant places on adaptive coping and recovery narratives | Up to 1 year |
| Percentage of Spirituality-themed Interview Content | This outcome is defined as the average percentage of narrative content within semi-structured qualitative interviews classified as "spirituality-themed" using Latent Dirichlet Allocation (LDA). This measure quantifies the relative focus a participant places on spiritual or existential frameworks as a component of their recovery. | Up to 1 year |
| Mean Narrative Sentiment Valence Score | A quantitative emotional-tone score calculated from participant interview transcripts using a standardized sentiment analysis algorithm. The score range is -1 to +1. A score of -1 represents a highly negative emotional valence, while a score of +1 represents a highly positive emotional valence. Higher scores indicate a more positive emotional narrative. | Up to 1 year |
| Incremental Variance (∆R2) in Stress-Induced Opioid Demand Predicted by NLP Indices | This outcome measures the change in R-squared (∆R2) when NLP-derived indices (topic proportions and sentiment) are added to a sequential regression model that already includes self-report and behavioral task scores. This measurement will be performed only on the subset of 45 participants who complete the qualitative interview sub-study. The outcome being predicted is the difference in opioid purchase breakpoints between the stress (MAST) and no-stress conditions. | From baseline up to 1 year |
| Johns Hopkins University Bayview Medical Campus |
| Recruiting |
| Baltimore |
| Maryland |
| 21224 |
| United States |
|